NEIAX
Price
$60.66
Change
+$0.48 (+0.80%)
Updated
Oct 24 closing price
Net Assets
3.19B
VTSMX
Price
$162.41
Change
+$1.29 (+0.80%)
Updated
Oct 24 closing price
Net Assets
2.02T
Interact to see
Advertisement

NEIAX vs VTSMX

Header iconNEIAX vs VTSMX Comparison
Open Charts NEIAX vs VTSMXBanner chart's image
Columbia Large Cap Index A
Price$60.66
Change+$0.48 (+0.80%)
VolumeN/A
Net Assets3.19B
Vanguard Total Stock Mkt Idx I
Price$162.41
Change+$1.29 (+0.80%)
VolumeN/A
Net Assets2.02T
NEIAX vs VTSMX Comparison Chart in %
View a ticker or compare two or three
VS
NEIAX vs. VTSMX commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEIAX is a Hold and VTSMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 2.02T vs. NEIAX (3.19B). VTSMX pays higher dividends than NEIAX: VTSMX (1.04) vs NEIAX (0.84). NEIAX was incepted earlier than VTSMX: NEIAX (30 years) vs VTSMX (34 years). NEIAX (0.45) is less costly to investors than VTSMX (0.14). NEIAX is a more actively managed with annual turnover of: 6.00 vs. VTSMX (2.00). NEIAX has a lower initial minimum investment than VTSMX: NEIAX (2000) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 16.88 vs. NEIAX (-0.98). VTSMX return over 5 years is better than : 89.39 vs. NEIAX (18.45).
NEIAXVTSMXNEIAX / VTSMX
Total Expense Ratio0.450.14321%
Annual Report Gross Expense Ratio0.450.14321%
Fund Existence30 years34 years-
Gain YTD3.73915.25525%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets3.19B2.02T0%
Annual Yield % from dividends0.841.0481%
Returns for 1 year-0.9816.88-6%
Returns for 3 years31.8573.4343%
Returns for 5 years18.4589.3921%
Returns for 10 years65.20227.6229%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR3.800.71
+22.98%
X4 Pharmaceuticals Inc
TRIB1.000.05
+5.67%
Trinity Biotech plc
CCOI42.960.24
+0.56%
Cogent Communications Holdings
MANH194.850.17
+0.09%
Manhattan Associates
EQV10.44N/A
N/A
EQV Ventures Acquisition Corp